New cancer clinical trial: Vinorelbine Plus Apatinib Versus Vinorelbine in Advanced Triple-Negative Breast Cancer
Published on: August 17, 2017 at 10:00AM
Condition: Advanced Triple-Negative Breast Cancer
Interventions: Drug: Vinorelbine; Drug: Apatinib
Sponsor: Fudan University
Recruiting – verified August 2017
http://ift.tt/2uYMroQ
More Stories
‘My 401k Misses You’: Black Woman Pumped To Meet Donald Trump In Philadelphia – July 18, 2023 at 04:56PM
Energy Provider Warns of Impending ‘Crisis,’ ‘Blackout Conditions’ Driven By Biden Plans – July 18, 2023 at 04:20PM
Dog starts barking at cows crossing a bridge, so the cows stop to have a look. – July 17, 2023 at 02:27PM